March 10, 2006

Encision Executives Appear on ABC Affiliate

Boulder, Colorado, March 10, 2006 -- Encision Inc. (Amex: ECI), a medical device company with patented surgical technology emerging as a standard of care in minimally-invasive surgery, announced that Jack Serino, President & CEO, and Roger Odell, Chairman and Co-Founder, appeared on the Denver ABC Affiliate, KMGH, Channel 7, in conjunction with National Patient Safety Awareness Week.

“We are pleased that we were invited to tell our story of how Encision’s AEM® instruments offer a technology solution to prevent serious complications, including death, from stray energy burns during laparoscopy,” said Jack Serino, President & CEO of Encision. “Medical and nursing professional societies have already joined the movement to reduce complications and deaths from medical and surgical errors through improved procedures, practices and education. As a partner in patient safety, we believe that technology can also contribute to the fight against preventable medical and surgical deaths.”

In late 1999, the Institute of Medicine (IOM) issued its landmark report on medical errors, To Err is Human: Building a Safer Health System. The report estimated that there are 44,000 to 98,000 deaths annually due to medical errors. The Agency for Healthcare Research and Quality has reported that, based on the IOM’s lower estimate of 44,000 deaths annually, medical errors rank as the eighth leading cause of death in the United States – higher than motor vehicle accidents (43,458), breast cancer (42,297) or AIDS (16,516).

Encision Inc. designs and manufactures innovative surgical devices that allow the surgeon to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM® Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase revenues through the Company's distribution channels, insufficient quantity of new account conversions, insufficient cash to fund operations, scale up production to meet delivery obligations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission.

CONTACT: Marcia McHaffie, Encision Inc., 303-444-2600, mmchaffie@encision.com

###